Michael Savin, MD
Vascular & Interventional Radiology · Royal Oak, MINPI 1821059049
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $49,213 of the $69,218 with a category attached, or 71.1%. Boston Scientific accounts for 80.3% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2023 at $42,443 and has fallen 85.8% since, to $6,029 in 2025. Among vascular & interventional radiology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 95 payments — averaging $728.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$56K
- Angiodynamics, Inc.$13K
- Bard Peripheral Vascular, Inc.$241
- Medtronic$151
- Terumo Medical Corporation$129
- Cardiovascular Systems Inc.$88
- plus $112 from 4 others
Across 3 payments — averaging $1683.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Inari Medical, Inc.$5K
What the payments were for
- Speaking & faculty fees$49,21371%
- Travel & lodging$4,5437%
- Food & beverage$2,6894%
- Education$500%
- Other$12,72318%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 72 | $55,604 |
| Angiodynamics, Inc. | 7 | $12,892 |
| Bard Peripheral Vascular, Inc. | 5 | $241 |
| Medtronic | 1 | $151 |
| Terumo Medical Corporation | 3 | $129 |
| Cardiovascular Systems Inc. | 1 | $88 |
| Sirtex Medical Inc | 3 | $54 |
| Cook Medical LLC | 1 | $21 |
| Argon Medical Devices, Inc. | 1 | $19 |
| Penumbra, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)$30,249
- TheraSphere Y90 Glass Microspheres 10 GBq$24,347
- Solero$12,723
- Concerto$151
- LUTONIX$121
- AlphaVac$112
How this compares
$69,218 in reported general payments places this provider in the 95th percentile of 118 vascular & interventional radiology providers in Michigan.
See all vascular & interventional radiology providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 27 | $125 |
| Ciprofloxacin Hcl | 21 | $55 |
| Ibuprofen | 20 | $33 |
Paid to pharmacies, not to this prescriber.
Other vascular & interventional radiology in Royal Oak
- Purushottam DixitRoyal Oak$4K
- Vincent ShallalRoyal Oak$3K
- Jacob ConroyRoyal Oak$3K
- Michael KnoxGrand Rapids$312K
- Jeffrey CritchfieldDetroit$145K
- Minhajuddin KhajaAnn Arbor$91K
- Wael SaadAnn Arbor$87K
- William SlaterGrand Rapids$25K
- Jacob HakkolaMarquette$24K
- Stephen VartanianFarmington Hills$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.